300759 康龙化成
已收盘 01-09 15:00:00
资讯
新帖
简况
Norges Bank减持康龙化成(03759)365.95万股 每股作价约20.66港元
智通财经网 · 01-07
Norges Bank减持康龙化成(03759)365.95万股 每股作价约20.66港元
康龙化成（300759）披露截至2025年12月31日证券变动月报表，1月6日股价上涨1.36%
证券之星 · 01-06
康龙化成（300759）披露截至2025年12月31日证券变动月报表，1月6日股价上涨1.36%
小摩增持康龙化成(03759)约145.62万股 每股作价约19.39港元
智通财经网 · 01-05
小摩增持康龙化成(03759)约145.62万股 每股作价约19.39港元
1月5日康龙化成涨5.87%，中欧医疗健康混合A基金重仓该股
证券之星 · 01-05
1月5日康龙化成涨5.87%，中欧医疗健康混合A基金重仓该股
康龙化成涨5.87%，浦银国际证券二个月前给出“买入”评级，目标价39.60元
证券之星 · 01-05
康龙化成涨5.87%，浦银国际证券二个月前给出“买入”评级，目标价39.60元
康龙化成：多位股东减持完毕
南方财经网 · 2025-12-24
康龙化成：多位股东减持完毕
股市必读：12月23日康龙化成现1笔大宗交易 机构净买入4282.5万元
证券之星 · 2025-12-24
股市必读：12月23日康龙化成现1笔大宗交易 机构净买入4282.5万元
股市必读：12月22日康龙化成现1笔大宗交易 机构净买入4312.5万元
证券之星 · 2025-12-23
股市必读：12月22日康龙化成现1笔大宗交易 机构净买入4312.5万元
港股异动 | CRO概念股承压走低 康龙化成(03759)跌超4% 昭衍新药(06127)跌超3%
智通财经 · 2025-12-22
港股异动 | CRO概念股承压走低 康龙化成(03759)跌超4% 昭衍新药(06127)跌超3%
医药外包概念股逆市受压 康龙化成(03759)跌4.14% 机构指美生物安全法案对华CXO企业经营影响有限
金吾财讯 · 2025-12-22
医药外包概念股逆市受压 康龙化成(03759)跌4.14% 机构指美生物安全法案对华CXO企业经营影响有限
康龙化成：2025年第一次临时股东大会决议公告
证券日报 · 2025-12-18
康龙化成：2025年第一次临时股东大会决议公告
康龙化成(03759)：曾劲峰获委任为独立非执行董事
智通财经 · 2025-12-18
康龙化成(03759)：曾劲峰获委任为独立非执行董事
康龙化成（300759）披露持股5%以上股东持股变动触及1%整数倍公告，12月12日股价上涨2.96%
证券之星 · 2025-12-12
康龙化成（300759）披露持股5%以上股东持股变动触及1%整数倍公告，12月12日股价上涨2.96%
康龙化成（300759）披露截至11月30日证券变动月报表，12月03日股价下跌0.55%
证券之星 · 2025-12-03
康龙化成（300759）披露截至11月30日证券变动月报表，12月03日股价下跌0.55%
康龙化成（300759）披露召开2025年第一次临时股东大会通知，11月27日股价下跌0.07%
证券之星 · 2025-11-27
康龙化成（300759）披露召开2025年第一次临时股东大会通知，11月27日股价下跌0.07%
康龙化成拟26倍PE并购 关联方最高回报率达151%
中国经营网 · 2025-11-22
康龙化成拟26倍PE并购 关联方最高回报率达151%
港股异动 | CRO概念股集体下跌 金斯瑞生物科技(01548)跌超6% 康龙化成(03759)跌超4%
智通财经 · 2025-11-21
港股异动 | CRO概念股集体下跌 金斯瑞生物科技(01548)跌超6% 康龙化成(03759)跌超4%
新股前瞻|“囤猴”拖累利润表现，鼎泰药物“卖水人”故事不好讲？
智通财经 · 2025-11-20
新股前瞻|“囤猴”拖累利润表现，鼎泰药物“卖水人”故事不好讲？
康龙化成：收购无锡佰翱得将产生积极影响
中金财经 · 2025-11-18
康龙化成：收购无锡佰翱得将产生积极影响
康龙化成跌5.34%，浦银国际证券二周前给出“买入”评级，目标价39.60元
证券之星 · 2025-11-17
康龙化成跌5.34%，浦银国际证券二周前给出“买入”评级，目标价39.60元
加载更多
公司概况
公司名称：
康龙化成(北京)新药技术股份有限公司
所属行业：
研究和试验发展
上市日期：
2019-01-28
主营业务：
康龙化成(北京)新药技术股份有限公司的主营业务是提供从药物发现到药物开发的全流程一体化药物研究、开发及生产服务。公司的主要产品是实验室服务、CMC（小分子CDMO）服务、临床研究服务、大分子和细胞与基因治疗服务。2025年，公司获得了标普全球SPGlobal颁发的“行业推进者”（IndustryMover）称号。
发行价格：
7.66
{"stockData":{"symbol":"300759","market":"SZ","secType":"STK","nameCN":"康龙化成","latestPrice":31.59,"timestamp":1767942237000,"preClose":31.18,"halted":0,"volume":24736377,"delay":0,"changeRate":0.0131,"floatShares":1419000000,"shares":1778000000,"eps":0.8506,"marketStatus":"已收盘","change":0.41,"latestTime":"01-09 15:00:00","open":31.18,"high":31.78,"low":30.94,"amount":776000000,"amplitude":0.0269,"askPrice":31.6,"askSize":359,"bidPrice":31.59,"bidSize":3,"shortable":0,"etf":0,"ttmEps":0.8506,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768181400000},"marketStatusCode":5,"adr":0,"adjPreClose":31.18,"symbolType":"stock","openAndCloseTimeList":[[1767922200000,1767929400000],[1767934800000,1767942000000]],"highLimit":34.3,"lowLimit":28.06,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1778195525,"isCdr":false,"pbRate":3.79,"roa":"--","peRate":37.13849,"roe":"8.05%","epsLYR":1.0133,"committee":0.129239,"marketValue":56173000000,"turnoverRate":0.0174,"status":0,"hkstockBrief":{"symbol":"03759","market":"HK","secType":"STK","nameCN":"康龙化成","latestPrice":23.18,"timestamp":1767946115008,"preClose":22.96,"halted":0,"volume":3894204,"delay":0,"premium":"-34.33"},"floatMarketCap":44838000000},"requestUrl":"/m/hq/s/300759","defaultTab":"news","newsList":[{"id":"2601872972","title":"Norges Bank减持康龙化成(03759)365.95万股 每股作价约20.66港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601872972","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601872972?lang=zh_cn&edition=full","pubTime":"2026-01-07 18:59","pubTimestamp":1767783599,"startTime":"0","endTime":"0","summary":"香港联交所最新资料显示，1月5日，Norges Bank减持康龙化成(03759)365.95万股，每股作价20.6572港元，总金额约为7559.50万港元。","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20260107/20260107190034_56292.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260107/20260107190034_56292.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1389973.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["03759","BK0216","300759","BK1576","BK1141"],"gpt_icon":0},{"id":"2601813889","title":"康龙化成（300759）披露截至2025年12月31日证券变动月报表，1月6日股价上涨1.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601813889","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601813889?lang=zh_cn&edition=full","pubTime":"2026-01-06 22:12","pubTimestamp":1767708744,"startTime":"0","endTime":"0","summary":"截至2026年1月6日收盘，康龙化成报收于30.51元，较前一交易日上涨1.36%，最新总市值为542.53亿元。公司近日发布公告，披露截至2025年12月31日的证券变动月报表。公告显示，康龙化成H股和A股的法定注册资本均无变动。H股总数为301,537,125股，其中已发行股份294,273,825股，库存股7,263,300股；A股总数为1,476,658,400股，全部已发行，无库存股。库存H股系公司在2024年12月及2025年1月购回，已指定用于2025年H股奖励信托计划。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600042333.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03759","BK1141","161027","BK1576","300759","BK0216"],"gpt_icon":0},{"id":"2601466883","title":"小摩增持康龙化成(03759)约145.62万股 每股作价约19.39港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601466883","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601466883?lang=zh_cn&edition=full","pubTime":"2026-01-05 18:55","pubTimestamp":1767610559,"startTime":"0","endTime":"0","summary":"12月30日，小摩增持康龙化成(03759)145.6225万股，每股作价19.388港元，总金额约为2823.33万港元。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/image/20260105/20260105185714_38340.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260105/20260105185714_38340.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1388769.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU2211815571.USD","IE00BKDWB100.SGD","BK4207","BK4581","LU2746668461.USD","IE00BZ1G4Q59.USD","LU0070302665.USD","LU2456880835.USD","LU2746668974.SGD","03759","IE00BJTD4N35.SGD","LU1629891620.HKD","LU1119994496.HKD","IE0034235295.USD","LU1548497426.USD","LU1974910355.USD","IE00BN8TJ469.HKD","LU0265550359.USD","LU0256863811.USD","LU1914381329.SGD","BK4534","LU0345770308.USD","LU2430703251.USD","LU1363072403.SGD","BK1576","LU2054465674.USD","LU0203345920.USD","LU0208291251.USD","IE00BWXC8680.SGD","LU1261432733.SGD","LU0211331839.USD","LU1551013342.USD","LU0170899867.USD","LU2106854487.HKD","LU0345769128.USD","LU0943347566.SGD","LU1670627923.USD","IE00BHPRN162.USD","BK4588","LU0251132253.USD","300759","LU1116320901.HKD","LU2237443465.HKD","IE000M9KFDE8.USD","LU2552382058.USD","LU0820561909.HKD","LU2756315664.SGD","LU2592432038.USD","LU0106831901.USD","IE00B1XK9C88.USD"],"gpt_icon":0},{"id":"2601006567","title":"1月5日康龙化成涨5.87%，中欧医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2601006567","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601006567?lang=zh_cn&edition=full","pubTime":"2026-01-05 15:46","pubTimestamp":1767599167,"startTime":"0","endTime":"0","summary":"证券之星消息，1月5日康龙化成涨5.87%，收盘报30.1元，换手率2.7%，成交量38.39万手，成交额11.37亿元。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共73家，其中持有数量最多的公募基金为中欧基金的中欧医疗健康混合A。中欧医疗健康混合A目前规模为169.77亿元，最新净值1.7737，较上一交易日下跌0.47%，近一年上涨13.07%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500015822.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159760","BK1576","BK0216","03759","300759","BK1141"],"gpt_icon":0},{"id":"2601065060","title":"康龙化成涨5.87%，浦银国际证券二个月前给出“买入”评级，目标价39.60元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601065060","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601065060?lang=zh_cn&edition=full","pubTime":"2026-01-05 15:46","pubTimestamp":1767599161,"startTime":"0","endTime":"0","summary":"今日康龙化成涨5.87%，收盘报30.1元。2025年11月3日，浦银国际证券研究员阳景,胡泽宇发布了对康龙化成的研报《新签订单进一步提速，上调全年收入指引》，该研报对康龙化成给出“买入”评级，认为其目标价为39.6元，现价距离目标价尚有31.56%的涨幅空间。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为93.74%。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为民生证券的孙建、郭双喜。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500015820.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","300759","03759"],"gpt_icon":0},{"id":"2593475839","title":"康龙化成：多位股东减持完毕","url":"https://stock-news.laohu8.com/highlight/detail?id=2593475839","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593475839?lang=zh_cn&edition=full","pubTime":"2025-12-24 17:37","pubTimestamp":1766569070,"startTime":"0","endTime":"0","summary":"南财智讯12月24日电，康龙化成公告，公司持股5%以上股东深圳市信中康成投资合伙企业（有限合伙）及其一致行动人深圳市信中龙成投资合伙企业（有限合伙）本次减持计划已实施完毕。其中，信中康成通过大宗交易方式减持889.0977万股，占公司总股本的0.50%；信中龙成通过集中竞价交易方式减持1778.19万股，占公司总股本的1.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512243600814456.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0216","BK1576","300759","03759","BK1141"],"gpt_icon":0},{"id":"2593414015","title":"股市必读：12月23日康龙化成现1笔大宗交易 机构净买入4282.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593414015","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593414015?lang=zh_cn&edition=full","pubTime":"2025-12-24 01:24","pubTimestamp":1766510654,"startTime":"0","endTime":"0","summary":"截至2025年12月23日收盘，康龙化成报收于28.81元，下跌0.69%，换手率0.96%，成交量13.65万手，成交额3.94亿元。当日关注点来自交易信息汇总：12月23日主力资金净流出3242.19万元，散户资金净流入2821.38万元。大宗交易12月23日康龙化成发生1笔大宗交易，机构净买入4282.5万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400000662.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300759","BK1576","03759","BK1141"],"gpt_icon":0},{"id":"2593756431","title":"股市必读：12月22日康龙化成现1笔大宗交易 机构净买入4312.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593756431","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593756431?lang=zh_cn&edition=full","pubTime":"2025-12-23 01:13","pubTimestamp":1766423595,"startTime":"0","endTime":"0","summary":"截至2025年12月22日收盘，康龙化成报收于29.01元，下跌1.46%，换手率1.43%，成交量20.36万手，成交额5.92亿元。当日关注点来自交易信息汇总：12月22日主力资金净流入1712.12万元，显示主力对康龙化成的积极介入。来自交易信息汇总：同日发生1笔大宗交易，机构净买入4312.5万元，反映机构投资者的显著增持行为。来自交易信息汇总：游资资金净流出3629.05万元，表明短线资金在当日选择离场。大宗交易12月22日康龙化成现1笔大宗交易，机构净买入4312.5万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300000625.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","BK1576","03759","300759","BK0216"],"gpt_icon":0},{"id":"2593710420","title":"港股异动 | CRO概念股承压走低 康龙化成(03759)跌超4% 昭衍新药(06127)跌超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593710420","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593710420?lang=zh_cn&edition=full","pubTime":"2025-12-22 15:24","pubTimestamp":1766388287,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，CRO概念股承压走低，截至发稿，康龙化成跌4.32%，报21.24港元；昭衍新药跌3.29%，报21.16港元；凯莱英跌2.31%，报78.15港元；维亚生物跌1.98%，报1.98港元。信达证券指，过去两年《生物安全法案》是压制CXO板块估值的重要原因，和最初版本相比，最终落地的版本没有点名具体企业，整体相对温和。虑到美联储已经进入降息通道，全球生物医药投融资有望边际改善，随着法案落地，CXO板块有望迎来业绩和估值的双重修复。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384340.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","BK1191","300759","01873","BK1576","BK0216","03759","06821","06127","603127"],"gpt_icon":0},{"id":"2593657109","title":"医药外包概念股逆市受压 康龙化成(03759)跌4.14% 机构指美生物安全法案对华CXO企业经营影响有限","url":"https://stock-news.laohu8.com/highlight/detail?id=2593657109","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593657109?lang=zh_cn&edition=full","pubTime":"2025-12-22 14:06","pubTimestamp":1766383579,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药外包概念股逆市受压，截至发稿，康龙化成 跌4.14%，药明生物跌3.75%，药明康德跌2.89%，昭衍新药跌2.67%，泰格医药跌2.07%，金斯瑞生物科技跌1.36%。招银国际表示，MSCI中国医疗指数2025年初至今累计上涨51.9%，跑赢MSCI中国指数24.3%。近期，医药板块有所回调。政策端方面，《生物安全法案》虽已签署生效，但鉴于其未波及Medicaid和Medicare的采购且对关联方定义明确，以及中国CXO美国行政机构收入占比较小，该机构预计该法案对中国CXO企业实质经营影响有限。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250110/ZDlhMzNiODA0MWQ5OWM0NDQ5YzUxMTZmZWRlMTczNjQ3MzM4NzkwNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/ZDlhMzNiODA0MWQ5OWM0NDQ5YzUxMTZmZWRlMTczNjQ3MzM4NzkwNQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1972004","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06127","LU0516423174.USD","02359","02269","LU0051755006.USD","LU0417516738.SGD","HK0000306701.USD","LU0326950275.SGD","LU0516422440.USD","LU0572944931.SGD","LU0140636845.USD","159938","BK1583","LU0359202008.SGD","LU0516423091.SGD","LU1046422090.SGD","BK1576","BK1161","BK0216","LU3063872942.SGD","09939","LU0327786744.USD","BK1589","LU1880383366.USD","01548","LU0348735423.USD","BK1141","LU0823426308.USD","SG9999002463.SGD","SG9999002562.SGD","LU0359201612.USD","LU2125910500.SGD","03759","LU0348825331.USD","300759","LU0417516902.SGD","LU2039709279.SGD","BK1574","LU0320764599.SGD","LU1242518931.SGD","HK0000306685.HKD","LU1720050803.USD","CXO","HK0000320264.USD","LU0708995583.HKD","LU0456846285.SGD","03347","HK0000320223.HKD","BK1610","LU0819121731.USD"],"gpt_icon":0},{"id":"2592909036","title":"康龙化成：2025年第一次临时股东大会决议公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2592909036","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592909036?lang=zh_cn&edition=full","pubTime":"2025-12-18 21:42","pubTimestamp":1766065326,"startTime":"0","endTime":"0","summary":"证券日报网讯12月18日晚间，康龙化成发布公告称，公司2025年第一次临时股东大会审议通过《关于补选公司第三届董事会独立非执行董事的议案》等多项议案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512183595740121.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0216","300759","BK1141","03759","BK1576"],"gpt_icon":0},{"id":"2592139905","title":"康龙化成(03759)：曾劲峰获委任为独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2592139905","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592139905?lang=zh_cn&edition=full","pubTime":"2025-12-18 20:45","pubTimestamp":1766061924,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康龙化成(03759)发布公告，由于相关决议案已于临时股东大会上正式通过，曾劲峰教授已获委任为第三届董事会独立非执行董事，自2025年12月18日起生效。此外，曾坤鸿先生已离任独立非执行董事、董事会审计委员会委员、董事会薪酬及考核委员会委员、董事会提名委员会委员，自曾劲峰教授于2025年12月18日获委任为独立非执行董事时生效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1383336.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1576","03759","BK0216","300759","BK1141"],"gpt_icon":0},{"id":"2590572051","title":"康龙化成（300759）披露持股5%以上股东持股变动触及1%整数倍公告，12月12日股价上涨2.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590572051","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590572051?lang=zh_cn&edition=full","pubTime":"2025-12-12 17:52","pubTimestamp":1765533155,"startTime":"0","endTime":"0","summary":"截至2025年12月12日收盘，康龙化成报收于29.91元，较前一交易日上涨2.96%，最新总市值为531.86亿元。公司近日发布公告称，持股5%以上股东深圳市信中康成投资合伙企业及其一致行动人深圳市信中龙成投资合伙企业因减持股份，导致持股比例变动触及1%整数倍。2025年7月10日至12月10日期间，两股东合计减持17,782,019股，占公司总股本的1.00%。其中信中康成减持15,553,519股，信中龙成减持2,228,500股。减持后，两股东合计持股比例由15.00%降至14.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121200028653.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","BK1576","300759","03759","BK1141"],"gpt_icon":0},{"id":"2588011983","title":"康龙化成（300759）披露截至11月30日证券变动月报表，12月03日股价下跌0.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588011983","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588011983?lang=zh_cn&edition=full","pubTime":"2025-12-03 17:06","pubTimestamp":1764752764,"startTime":"0","endTime":"0","summary":"截至2025年12月3日收盘，康龙化成报收于28.84元，较前一交易日下跌0.55%，最新总市值为512.83亿元。公司近日发布公告，披露截至2025年11月30日的证券变动月报表。公告显示，康龙化成H股和A股的法定注册资本均无变动。H股总数为301,537,125股，其中已发行股份294,273,825股，库存股7,263,300股；A股总数为1,476,658,400股，全部已发行，无库存股。库存H股系公司在2024年12月及2025年1月购回，已指定用于2025年H股奖励信托计划。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120300025748.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","03759","300759","161027","BK0216","BK1141"],"gpt_icon":0},{"id":"2586223756","title":"康龙化成（300759）披露召开2025年第一次临时股东大会通知，11月27日股价下跌0.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586223756","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586223756?lang=zh_cn&edition=full","pubTime":"2025-11-27 22:06","pubTimestamp":1764252383,"startTime":"0","endTime":"0","summary":"截至2025年11月27日收盘，康龙化成报收于28.87元，较前一交易日下跌0.07%，最新总市值为513.37亿元。近日，康龙化成发布公告称，公司董事会决定于2025年12月18日召开2025年第一次临时股东大会，会议将审议补选第三届董事会独立非执行董事、修订多项公司治理制度及《公司章程》《股东大会议事规则》《董事会议事规则》等11项议案。股权登记日为2025年12月12日，A股股东可通过现场或网络投票方式参会。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700038117.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","300759","BK0216","BK1141","03759"],"gpt_icon":0},{"id":"2585123287","title":"康龙化成拟26倍PE并购 关联方最高回报率达151%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585123287","media":"中国经营网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585123287?lang=zh_cn&edition=full","pubTime":"2025-11-22 03:48","pubTimestamp":1763754533,"startTime":"0","endTime":"0","summary":"11月17日，针对拟以13.46亿元收购无锡佰翱得生物科学股份有限公司（以下简称“无锡佰翱得”）82.54%的股份事项，康龙化成（03759.HK，300759.SZ）发布了有关收购佰翱得82.54%股份构成关联交易。11月19日，康龙化成方面对《中国经营报》记者表示：“本次交易在正常推进中，请关注后续的进展公告。”康龙化成方面未详细回应记者更多相关问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511223571789075.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0216","03759","300759","BK1576","BK1141"],"gpt_icon":0},{"id":"2585150194","title":"港股异动 | CRO概念股集体下跌 金斯瑞生物科技(01548)跌超6% 康龙化成(03759)跌超4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585150194","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585150194?lang=zh_cn&edition=full","pubTime":"2025-11-21 14:45","pubTimestamp":1763707525,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，CRO概念股集体下跌，截至发稿，金斯瑞生物科技跌6.05%，报14.92港元；康龙化成跌4.67%，报20.8港元；维亚生物跌4.57%，报1.88港元；泰格医药跌3.71%，报36.9港元。消息面上，昨晚公布的美国9月非农大超预期，数据公布后，互换合约继续显示美联储12月降息的可能性萎缩。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1372006.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000320264.USD","01548","HK0000306701.USD","01873","BK0216","BK1583","BK1141","HK0000306685.HKD","03759","BK1576","HK0000320223.HKD","03347","300759"],"gpt_icon":0},{"id":"2584047902","title":"新股前瞻|“囤猴”拖累利润表现，鼎泰药物“卖水人”故事不好讲？","url":"https://stock-news.laohu8.com/highlight/detail?id=2584047902","media":"智通财经","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584047902?lang=zh_cn&edition=full","pubTime":"2025-11-20 13:38","pubTimestamp":1763617114,"startTime":"0","endTime":"0","summary":"得益于这一强劲的行业“暖风”，鼎泰药物的上市计划已成为当前市场关注的焦点之一。收入稳中有升 实验动物价格波动拖累利润尽管行业整体呈现复苏态势，鼎泰药物的内部经营却呈现出“外热内冷”的局面。从财务表现来看，往绩期间公司营收整体保持平稳，净利润则出现下滑趋势。尽管业务呈现回暖迹象，但鼎泰药物的财务状况仍存在隐忧。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1371458.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300759","06127","BK1141","03347","BK0216","BK1576","BK1583"],"gpt_icon":0},{"id":"2584380729","title":"康龙化成：收购无锡佰翱得将产生积极影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2584380729","media":"中金财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584380729?lang=zh_cn&edition=full","pubTime":"2025-11-18 17:49","pubTimestamp":1763459364,"startTime":"0","endTime":"0","summary":"本次交易完成后，目标公司可能面临后续经营管理、人才管理、业务整合等相关风险，公司将督促和指导目标公司积极采取有效措施和对策控制和化解风险，敬请广大投资者注意投资风险。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251118/31805542.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0216","300759","BK1576","03759","BK1141"],"gpt_icon":0},{"id":"2584364364","title":"康龙化成跌5.34%，浦银国际证券二周前给出“买入”评级，目标价39.60元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584364364","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584364364?lang=zh_cn&edition=full","pubTime":"2025-11-17 16:34","pubTimestamp":1763368477,"startTime":"0","endTime":"0","summary":"今日康龙化成跌5.34%，收盘报29.8元。2025年11月3日，浦银国际证券研究员阳景,胡泽宇发布了对康龙化成的研报《新签订单进一步提速，上调全年收入指引》，该研报对康龙化成给出“买入”评级，认为其目标价为39.6元，研报发布时股价为33.51元，预期涨幅为18.17%。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为70.0%。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为招商证券的梁广楷。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111700020928.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","300759","03759"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1768172695937,"stockEarnings":[{"period":"1week","weight":0.1112},{"period":"1month","weight":0.0756},{"period":"3month","weight":-0.045},{"period":"6month","weight":0.1687},{"period":"1year","weight":0.2947},{"period":"ytd","weight":0.1112}],"compareEarnings":[{"period":"1week","weight":0.0382},{"period":"1month","weight":0.0564},{"period":"3month","weight":0.0573},{"period":"6month","weight":0.1739},{"period":"1year","weight":0.2831},{"period":"ytd","weight":0.0382}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"康龙化成(北京)新药技术股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"0人","perCapita":"--","listingDate":"2019-01-28","address":"北京市大兴区北京经济技术开发区泰河路6号1幢八层","registeredCapital":"177819万元","survey":" 康龙化成(北京)新药技术股份有限公司的主营业务是提供从药物发现到药物开发的全流程一体化药物研究、开发及生产服务。公司的主要产品是实验室服务、CMC（小分子CDMO）服务、临床研究服务、大分子和细胞与基因治疗服务。2025年，公司获得了标普全球SPGlobal颁发的“行业推进者”（IndustryMover）称号。","listedPrice":7.66},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康龙化成(300759)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康龙化成(300759)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康龙化成,300759,康龙化成股票,康龙化成股票老虎,康龙化成股票老虎国际,康龙化成行情,康龙化成股票行情,康龙化成股价,康龙化成股市,康龙化成股票价格,康龙化成股票交易,康龙化成股票购买,康龙化成股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康龙化成(300759)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康龙化成(300759)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}